News

Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable drugs. By Gina Kolata and Rebecca Robbins A daily pill may be as ...
The Ethics and Public Policy Center, a think tank that says it opposes “the extreme progressive agenda while building consensus of conservatives,” recently issued a report on a key abortion ...
Eli Lilly's experimental oral pill, orforglipron, has shown promising results in Phase 3 trials, effectively lowering weight and blood sugar levels similar to Ozempic in diabetes patients.
LONDON, May 13 (Reuters) - Bank of England Chief Economist Huw Pill said on Tuesday that he was worried that inflation in Britain could prove stronger than expected by the central bank and ...
Drugmaker Eli Lilly announced promising Phase 3 study results for its new GLP-1 pill. Orforglipron is a drug similar to Ozempic but without the injection, making it more accessible. The pill ...
California pregnancy centers filed an appeal last week asking the U.S. Court of Appeals for the 9th Circuit to stop the state from censoring pro-life pregnancy centers that provide abortion pill ...
Now, a GLP-1 in pill form is showing promising results for weight loss and blood sugar control — no needles required. The medication — orforglipron from pharmaceutical giant Eli Lilly — is ...
These undatable men are those who subscribe to the “red pill” notion, an alarming subculture that perpetuates a societal hatred against women by opposing feminist narratives and emphasizing ...
after the drugmaker reported positive results from a late-stage trial of a GLP-1 treatment for Type 2 diabetes and obesity in pill form. The last time the stock rose as much was June 29 ...
Twenty-eight states restrict access to mifepristone, according to the organization, four of which prohibit the mailing of abortion pills to patients. The filing from the Trump administration is ...
The jab averse can now rejoice! Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, stab-free way to treat diabetes and obesity.